Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 2, 2001, Pages 273-278

  Rogers, A S ^a   Ellenberg, J H ^a   Douglas, S D ^a   Henry Reid, L ^a   Peralta, L ^a   Wilson, C M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; TETANUS TOXOID;

ADOLESCENT; ADULT; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUMPS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; ANTIGENS, FUNGAL; CANDIDA ALBICANS; CD4 LYMPHOCYTE COUNT; CHILD; EPITOPES; FEMALE; HIV ANTIGENS; HIV INFECTIONS; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; MUMPS VIRUS; SEX FACTORS; TETANUS TOXOID;

EID: 0035099208     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.2.273-278.2001     Document Type: Article

References (26)

1. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1 infected and uninfected at-risk women
2. P values maximized over a confidence set for the nuisance parameter
3. Delayed type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients
4. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection
5. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: Guidelines for anergy testing and management of anergic persons at risk of tuberculosis
6. The comparison of percentages in matched samples
7. In vitro T cell function, delayed type hypersensitivity skin testing, and CD4 T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus
8. A novel Candida albicans skin test antigen: Efficacy and safety in man
9. Influence of aging on some specific and nonspecific mechanisms of the host defense system in 146 healthy subjects
10. Delayed type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression
11. Prevalence of tuberculin positivity and skin test anergy in HIV-1 seropositive and seronegative intravenous drug users
12. Delayed type hypersensitivity anergy in human immunodeficiency virus infected persons screened for infection with Mycobacterium tuberculosis
13. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients
14. Obtaining confidence intervals for the risk ratios in cohort studies
15. Criteria for assessing cutaneous anergy in women with or at risk for HIV infection
16. In vivo delayed type hypersensitivity skin test anergy in human immunodeficiency virus type I infection is associated with T-cell nonresponsiveness in vitro
17. Statistical aspects of the analysis of data from retrospective studies of disease
18. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons
19. Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients
20. The REACH project of the adolescent medicine HIV/AIDS research network: Design, methods, and selected characteristics of participants
21. The prevalence of anergy in human immunodeficiency virus-infected adolescents and the association of delayed-type hypersensitivity with subject characteristics
22. Small-sample confidence intervals for p1-p2 and p1/p2 in 2 × 2 contingency tables
23. Delayed hypersensitivity skin testing and anergy in a population of gay men
24. Early T-helper cell defects in HIV infection
25. + T-cell count?